ArticleReproductive biology and endocrinology : RB&E2026
The impact of fresh versus cryopreserved testicular sperm on in-vitro fertilization outcomes in couples with elevated sperm DNA fragmentation: a retrospective cohort study.
Article in Reproductive biology and endocrinology : RB&E, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundElevated sperm DNA fragmentation (SDF) is associated with male factor infertility, recurrent pregnancy loss, and poor reproductive outcomes. An option for management includes the utilization of testicular sperm; however, the comparative reproductive efficacy of fresh versus cryopreserved testicular sperm men with elevated SDF remains unclear. Therefore, the objective of this study was to identify differences in reproductive outcomes between fresh and cryopreserved testicular sperm in patients with elevated SDF who are undergoing intracytoplasmic sperm injection (ICSI) after testicular sperm extraction (TESE).
methodsThis was a retrospective cohort study of a multi-site fertility network of patients with elevated SDF who underwent TESE and subsequent ICSI using either fresh or cryopreserved testicular sperm.
resultsA total of 60 men with elevated SDF underwent TESE and subsequent IVF with ICSI. 66.7% (n = 40) used fresh testicular sperm while the remaining 33.3% (n = 20) used cryopreserved testicular sperm following TESE. There were no significant differences in patient demographics or SDF (median 46.5 (IQR: 34.0, 59.0) vs. 48.0 (IQR: 38.0, 64.0), p = 0.525) between those that used fresh or cryopreserved testicular sperm. Among all initiated treatment cycles, there was no statistically significant difference in cumulative live birth (42.5% vs. 25.0%, p = 0.656), clinical pregnancy (55.0% vs. 35.0% p = 0.144) or miscarriage rates (10% vs. 5.0%, p = 0.185) between fresh and cryopreserved testicular sperm. Similarly, there were no significant differences in fertilization (median 48.8 (IQR 33.5, 61.3) vs. 43.7 (IQR:32.8, 63.1), p = 0.937) or blastocyst conversion (median 16.7 (IQR: 0.0, 40.0) vs. 26.1 (IQR: 16.7, 52.8), p = 0.106).
conclusionLive birth, clinical pregnancy, miscarriage, fertilization and blastocyst yield were not significantly different when using fresh or cryopreserved testicular sperm in couples undergoing TESE for elevated SDF. Although this is the largest study examining these clinical outcomes to date, our study may have low statistical power and additional prospective studies with larger sample sizes are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.